| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |